LIFEMD INC (LFMD) Fundamental Analysis & Valuation

NASDAQ:LFMD • US53216B1044

Current stock price

3.72 USD
-0.22 (-5.58%)
At close:
3.8394 USD
+0.12 (+3.21%)
After Hours:

This LFMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. LFMD Profitability Analysis

1.1 Basic Checks

  • In the past year LFMD has reported negative net income.
  • In the past year LFMD had a positive cash flow from operations.
  • In the past 5 years LFMD reported 4 times negative net income.
  • In multiple years LFMD reported negative operating cash flow during the last 5 years.
LFMD Yearly Net Income VS EBIT VS OCF VS FCFLFMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • LFMD has a better Return On Assets (17.56%) than 97.14% of its industry peers.
  • With an excellent Return On Equity value of 53.38%, LFMD belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA 17.56%
ROE 53.38%
ROIC N/A
ROA(3y)-18.92%
ROA(5y)-73.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LFMD Yearly ROA, ROE, ROICLFMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5K -10K -15K

1.3 Margins

  • LFMD's Profit Margin of 5.26% is amongst the best of the industry. LFMD outperforms 88.57% of its industry peers.
  • LFMD's Gross Margin of 87.44% is amongst the best of the industry. LFMD outperforms 91.43% of its industry peers.
  • LFMD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 5.26%
GM 87.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.53%
GM growth 5Y2.4%
LFMD Yearly Profit, Operating, Gross MarginsLFMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. LFMD Health Analysis

2.1 Basic Checks

  • LFMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, LFMD has more shares outstanding
  • LFMD has more shares outstanding than it did 5 years ago.
  • LFMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LFMD Yearly Shares OutstandingLFMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
LFMD Yearly Total Debt VS Total AssetsLFMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 0.92, we must say that LFMD is in the distress zone and has some risk of bankruptcy.
  • LFMD has a Altman-Z score (0.92) which is in line with its industry peers.
  • There is no outstanding debt for LFMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.92
ROIC/WACCN/A
WACC10.06%
LFMD Yearly LT Debt VS Equity VS FCFLFMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

2.3 Liquidity

  • LFMD has a Current Ratio of 1.25. This is a normal value and indicates that LFMD is financially healthy and should not expect problems in meeting its short term obligations.
  • LFMD has a worse Current ratio (1.25) than 68.57% of its industry peers.
  • A Quick Ratio of 1.18 indicates that LFMD should not have too much problems paying its short term obligations.
  • LFMD has a worse Quick ratio (1.18) than 68.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.18
LFMD Yearly Current Assets VS Current LiabilitesLFMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. LFMD Growth Analysis

3.1 Past

  • LFMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.37%, which is quite impressive.
  • Looking at the last year, LFMD shows a quite strong growth in Revenue. The Revenue has grown by 10.59% in the last year.
  • The Revenue has been growing by 39.07% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)70.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)10.59%
Revenue growth 3Y17.7%
Revenue growth 5Y39.07%
Sales Q2Q%-27.06%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.26% on average over the next years. This is a very strong growth
  • LFMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.76% yearly.
EPS Next Y60.16%
EPS Next 2Y85.61%
EPS Next 3Y23.26%
EPS Next 5YN/A
Revenue Next Year-3.96%
Revenue Next 2Y7.38%
Revenue Next 3Y8.76%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LFMD Yearly Revenue VS EstimatesLFMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
LFMD Yearly EPS VS EstimatesLFMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. LFMD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for LFMD. In the last year negative earnings were reported.
  • Also next year LFMD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFMD Price Earnings VS Forward Price EarningsLFMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

  • LFMD's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 188.36
LFMD Per share dataLFMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LFMD's earnings are expected to grow with 23.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.61%
EPS Next 3Y23.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LFMD Dividend Analysis

5.1 Amount

  • No dividends for LFMD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LFMD Fundamentals: All Metrics, Ratios and Statistics

LIFEMD INC

NASDAQ:LFMD (3/27/2026, 8:00:03 PM)

After market: 3.8394 +0.12 (+3.21%)

3.72

-0.22 (-5.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-09
Earnings (Next)05-04
Inst Owners39.57%
Inst Owner Change-9.27%
Ins Owners17.81%
Ins Owner Change1.11%
Market Cap178.45M
Revenue(TTM)234.96M
Net Income(TTM)12.36M
Analysts81.43
Price Target9.95 (167.47%)
Short Float %16.37%
Short Ratio5.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP25.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.35%
Min EPS beat(2)-47.05%
Max EPS beat(2)-17.66%
EPS beat(4)1
Avg EPS beat(4)-145.36%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)2
Avg EPS beat(8)-75.65%
EPS beat(12)4
Avg EPS beat(12)-60.49%
EPS beat(16)5
Avg EPS beat(16)-55.17%
Revenue beat(2)0
Avg Revenue beat(2)-3.43%
Min Revenue beat(2)-4.95%
Max Revenue beat(2)-1.92%
Revenue beat(4)1
Avg Revenue beat(4)-2.99%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)2.97%
Revenue beat(8)4
Avg Revenue beat(8)-0.03%
Revenue beat(12)7
Avg Revenue beat(12)1.1%
Revenue beat(16)7
Avg Revenue beat(16)-1.52%
PT rev (1m)5.41%
PT rev (3m)5.41%
EPS NQ rev (1m)-207.29%
EPS NQ rev (3m)-637.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-208.7%
Revenue NQ rev (1m)-3%
Revenue NQ rev (3m)-3%
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)-1.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.76
P/FCF N/A
P/OCF 21.55
P/B 7.71
P/tB 14.52
EV/EBITDA 188.36
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.17
OCFY4.64%
SpS4.9
BVpS0.48
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 17.56%
ROE 53.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 5.26%
GM 87.44%
FCFM N/A
ROA(3y)-18.92%
ROA(5y)-73.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.53%
GM growth 5Y2.4%
F-Score6
Asset Turnover3.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 130.24%
Cap/Sales 4.05%
Interest Coverage N/A
Cash Conversion 1100.94%
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 1.18
Altman-Z 0.92
F-Score6
WACC10.06%
ROIC/WACCN/A
Cap/Depr(3y)127.27%
Cap/Depr(5y)201.22%
Cap/Sales(3y)5.99%
Cap/Sales(5y)5.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y60.16%
EPS Next 2Y85.61%
EPS Next 3Y23.26%
EPS Next 5YN/A
Revenue 1Y (TTM)10.59%
Revenue growth 3Y17.7%
Revenue growth 5Y39.07%
Sales Q2Q%-27.06%
Revenue Next Year-3.96%
Revenue Next 2Y7.38%
Revenue Next 3Y8.76%
Revenue Next 5YN/A
EBIT growth 1Y59.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year637.05%
EBIT Next 3Y154.03%
EBIT Next 5YN/A
FCF growth 1Y-120.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-52.72%
OCF growth 3YN/A
OCF growth 5YN/A

LIFEMD INC / LFMD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of LIFEMD INC (LFMD) stock?

ChartMill assigns a fundamental rating of 4 / 10 to LFMD.


What is the valuation status for LFMD stock?

ChartMill assigns a valuation rating of 1 / 10 to LIFEMD INC (LFMD). This can be considered as Overvalued.


What is the profitability of LFMD stock?

LIFEMD INC (LFMD) has a profitability rating of 4 / 10.


How financially healthy is LIFEMD INC?

The financial health rating of LIFEMD INC (LFMD) is 5 / 10.